Polypure clinches PEG deal with BD
This article was originally published in Clinica
Executive Summary
Polypure, an Oslo, Norway-based developer and manufacturer of PEG (polyethylene glycol) compounds, has struck a five-year deal with Becton Dickinson to supply its Biosciences subsidiary with monodisperse PEG derivatives. BD Biosciences will use the compounds in its existing and in-development diagnostic products. According to Polypure, its proprietary sample displacement chromatographic purification method enables the company to produce homogenous polymers with a high level of functional integrity. The single molecular weight of monodisperse PEGs also eliminates the characterisation problems of conventional polymer mixtures. These properties, in turn, improve cross-linking, binding and lot-to-lots reproducibility in the resulting diagnostic products, claims the firm.